Agilisium

Agilisium Agilisium is Life Sciences Industry’s Premier Data Innovation partner.

Agilisium collaborates with leading pharmaceutical, biotech and medical devices companies to provide data-driven insights and innovative solutions across the value chain—accelerating scientific innovation, improving patient outcomes, and enhancing access to affordable care. Recognized by top independent analyst firms such as the Everest Group and ISG, consulting leaders such as EY, and technology

giants like AWS, Agilisium stands out for its commitment to rigorous execution and continuous innovation, enabling it to shape the future of the life sciences industry.

Speed fuels strategy. In commercial operations, every second counts. Discover how a leading biopharma partnered with Agi...
12/22/2025

Speed fuels strategy. In commercial operations, every second counts.

Discover how a leading biopharma partnered with Agilisium to modernize its European data systems through cloud transformation, driving 3X faster forecasting, 2X automation efficiency, and 30% cost savings.

Smarter systems. Faster insights. Stronger decisions.

Unpack the approach: https://na2.hubs.ly/H02KmMP0

A proud moment for Agilisium! Dr. Girija Kalantre is representing us at IIT Bombay's TechConnect 2025. Another meaningfu...
12/19/2025

A proud moment for Agilisium!

Dr. Girija Kalantre is representing us at IIT Bombay's TechConnect 2025.

Another meaningful footprint for us at a premier institution shaping the future of AI in science and engineering.

RSVP: https://lnkd.in/dc9j4qk5
Event details: https://lnkd.in/dNHgGdwA

In commercial life sciences, timing defines success. A leading biopharma partnered with Agilisium to connect Salesforce ...
12/19/2025

In commercial life sciences, timing defines success.

A leading biopharma partnered with Agilisium to connect Salesforce and Veeva CRM, enabling precise HCP engagement through intelligent task automation and real time data flow. Discover how unified commercial insights empowered field teams to act faster, engage smarter, and deliver stronger outcomes across every therapeutic area.

See how it was achieved: https://na2.hubs.ly/H02KmKT0

Patient access is not just a process. It is a promise.A global biopharma partnered with Agilisium to bring together copa...
12/17/2025

Patient access is not just a process. It is a promise.

A global biopharma partnered with Agilisium to bring together copay, forecasting, and launch analytics into one connected cloud platform.

Built on AWS and Snowflake, the solution delivered up to 30 percent cost savings, 3x faster forecasting, and real time visibility across every patient access program.

See How It Works: https://na2.hubs.ly/H02Dhyw0

12/11/2025

A Day in the Life of a Scientist with AI

Join us for the 41st Edition of the Life Sciences DNA Podcast, where Gabi Tarcic, vice president of product at Evogene, sits down with Nagaraja Srivatsan.

Gabi Tarcic says “For discovery research scientists, AI cuts across all they do, but it is the predictive tools where AI gets interesting”.

He explains how AI accelerates literature review with large language models and clarifies experiment data through imaging and sequence tools, while also strengthening the full discovery science workflow by improving problem understanding, experiment analysis, and predictive modeling for faster, more confident research decisions.

Listen in to the full podcast on: https://na2.hubs.ly/H02wn7w0

Rare disease isn’t about volume — it’s about verification, influence, and real patient impact. Explore our whitepaper by...
12/02/2025

Rare disease isn’t about volume — it’s about verification, influence, and real patient impact. Explore our whitepaper by VARUN ARORA, PMP®, CBAP that introduces a model incentive compensation blueprint for rare disease markets.

This paper addresses the issues of Traditional IC such as an unbalanced view of sales contribution due to minor patient populations and long pathways to treatment in rare diseases.

It presents four tailored IC models – Verified Enrollment, Weighted Milestone, Hybrid Influence & Activation Plan and Opportunity-Based Goal Plan – designed specifically for rare or ultra-rare therapies where traditional sales KPIs break down.

Read more on how verifiable patient impact can create a more robust model modern IC framework for ultra-low volume rare disease markets here: https://na2.hubs.ly/H02kgjF0

HappyThanksgiving from all of us at Agilisium! We’re grateful for our people, partners, and the purpose that keeps us mo...
11/27/2025

HappyThanksgiving from all of us at Agilisium!

We’re grateful for our people, partners, and the purpose that keeps us moving forward.

In a rare disease, influence and verification carry more weight than raw activity counts.A new whitepaper on a modern in...
11/20/2025

In a rare disease, influence and verification carry more weight than raw activity counts.

A new whitepaper on a modern incentive design framework reveals how compensation can finally align with the real dynamics of ultra-low volume therapies.

Is your incentive model built for rare disease reality, or is it still running on assumptions from high-volume markets?

Read More: https://na2.hubs.ly/H028dWz0

DevOps Engineer - Walk-In Drive – Nov 25Agilisium is hiring experienced DevOps Engineers to join our team!Key Skills:➢ A...
11/20/2025

DevOps Engineer - Walk-In Drive – Nov 25

Agilisium is hiring experienced DevOps Engineers to join our team!

Key Skills:
➢ AWS/Azure Devops Terraform, Kubernetes ,CI/CD Platforms
➢ Scripting: Python, BASH , Shell Scripting

Requirements:
Experience: 5–10 years
Notice Period: Immediate to 15 days

Walk-in Details:
📍 Venue: World Trade Centre, Chennai
⏱️ Time: 11:00 AM – 3:00 PM

Registration Link: https://na2.hubs.ly/H027Qdc0

If you have the skills to build, automate, and optimize high-performing DevOps environments, we encourage you to walk in and explore opportunities with us.

Join us and elevate your career with Agilisium.

Life Sciences innovation depends on speed, scalability, and cost efficiency, yet traditional on-prem often slows progres...
11/14/2025

Life Sciences innovation depends on speed, scalability, and cost efficiency, yet traditional on-prem often slows progress. Moving to HPC Cloud unlocks new research capabilities, faster insights, and smarter resource utilization.

In our latest blog, we explore how Agilisium helps Life Sciences organizations overcome computational bottlenecks with cloud-native HPC solutions.

Know More: https://na2.hubs.ly/H023KQz0

Address

Suite 235, Westlake Village Executive Suites, 2629 Townsgate Road
Los Angeles, CA
91361

Alerts

Be the first to know and let us send you an email when Agilisium posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Agilisium:

Share